In 2018, industry revenue grew 3.5% over 2017. Results were mixed among the largest companies as some stumbled operationally while others overperformed, due in part to early adoption of technology and entry into high-growth segments.
In trauma, new products like Femoral Recon Nails gained traction supported by a growing market. Knee sales were impacted by competitive pressure in the U.S. We provide estimates for segment sales and growth, as well as orthopedic product sales by geographic region.
Austria-based BRI.Tech is the developer of a patented novel biocompatible and bioresorbable metal composition. Biotec, located in Finland, is developing projects that include fiber-reinforced biopolymer composite materials, and this transaction will add another material option to its portfolio.